Skeletal muscle channelopathy: genes and variants
Explore variant evidence for Skeletal muscle channelopathy across 3 analyzed proteins (CLCN1, SCN4A, CACNA1S). Linked ClinVar records include 18 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 5 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Skeletal muscle channelopathy
CLCN1: Chloride channel protein 1
Its chloride conductance stabilizes the resting membrane potential of skeletal muscle and prevents repetitive firing after contraction. Loss-of-function variants cause myotonia congenita, with delayed muscle relaxation and stiffness.
11 ClinVar pathogenic / likely pathogenic and 3 uncertain variants in CLCN1 have source records linked to Skeletal muscle channelopathy. Association strength is not clinical gene validity.
SCN4A: Sodium channel protein type 4 subunit alpha
Its rapid sodium current initiates and propagates skeletal-muscle action potentials. Gain- and loss-of-function variants cause disorders of muscle excitability including sodium-channel myotonia, paramyotonia congenita, periodic paralysis, and some congenital myopathies.
6 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in SCN4A have source records linked to Skeletal muscle channelopathy. Association strength is not clinical gene validity.
CACNA1S: Voltage-dependent L-type calcium channel subunit alpha-1S
Its voltage sensing in skeletal-muscle transverse tubules mechanically activates RYR1 and couples membrane depolarization to sarcoplasmic-reticulum calcium release. Pathogenic variants can cause hypokalemic periodic paralysis, malignant-hyperthermia susceptibility, and congenital myopathy.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CACNA1S have source records linked to Skeletal muscle channelopathy. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): PYGM and KCNJ2.
ClinVar pathogenic and likely pathogenic variants linked to Skeletal muscle channelopathy
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CLCN1 A313V | 313 | Transmembrane | Pathogenic / likely pathogenic (★★★★) |
| CLCN1 A566T | 566 | Helical | Pathogenic / likely pathogenic (★★★★) |
| SCN4A R1448H | 1448 | IV | Pathogenic / likely pathogenic (★★) |
| CLCN1 G355R | 355 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SCN4A R1132Q | 1132 | III | Pathogenic / likely pathogenic (★★) |
| SCN4A V1293I | 1293 | III | Pathogenic / likely pathogenic (★★) |
| SCN4A V1589M | 1589 | IV | Pathogenic / likely pathogenic (★★) |
| CACNA1S R1239H | 1239 | IV | Pathogenic / likely pathogenic (★★) |
| CLCN1 W164R | 164 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| CLCN1 G285E | 285 | Helical | Pathogenic / likely pathogenic (★★) |
| CLCN1 F413C | 413 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SCN4A L796V | 796 | II | Pathogenic / likely pathogenic (★★) |
| SCN4A G1306A | 1306 | III | Pathogenic / likely pathogenic (★★) |
| CLCN1 G200E | 200 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| CLCN1 W303R | 303 | Transmembrane | Pathogenic / likely pathogenic (★) |
| CLCN1 G650D | 650 | CBS 1 | Pathogenic / likely pathogenic (★) |
| CLCN1 G190A | 190 | Helical | Pathogenic / likely pathogenic (★) |
| CLCN1 A543T | 543 | Helical | Pathogenic / likely pathogenic (★) |
Which prediction tools work for Skeletal muscle channelopathy
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- VARITY: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 99 out of 100
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 97 out of 100
- MetaSVM: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 94 out of 100
- MetaLR: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 92 out of 100
- SIFT: 90 out of 100
- phyloP: 89 out of 100
- phastCons: 85 out of 100
- Pangolin: 52 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 49 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Myotonia, autosomal dominant form also has ClinVar records linked to CLCN1 variants; they fall mostly in different places as the Skeletal muscle channelopathy variants (92 pathogenic / likely pathogenic).
- Congenital myotonia, autosomal recessive form also has ClinVar records linked to CLCN1 variants; they fall mostly in different places as the Skeletal muscle channelopathy variants (90 pathogenic / likely pathogenic).
- Hyperkalemic periodic paralysis also has ClinVar records linked to SCN4A variants; they fall mostly in different places as the Skeletal muscle channelopathy variants (62 pathogenic / likely pathogenic).
- Paramyotonia congenita of Von Eulenburg also has ClinVar records linked to SCN4A variants; they fall mostly in different places as the Skeletal muscle channelopathy variants (15 pathogenic / likely pathogenic).
- Potassium-aggravated myotonia also has ClinVar records linked to SCN4A variants; they fall mostly in different places as the Skeletal muscle channelopathy variants (14 pathogenic / likely pathogenic).
- Hypokalemic periodic paralysis also has ClinVar records linked to SCN4A variants; they fall mostly in different places as the Skeletal muscle channelopathy variants (11 pathogenic / likely pathogenic).
- Congenital myopathy 22A, classic also has ClinVar records linked to SCN4A variants; they fall mostly in different places as the Skeletal muscle channelopathy variants (8 pathogenic / likely pathogenic).
- Hypokalemic periodic paralysis also has ClinVar records linked to CACNA1S variants; they fall mostly in different places as the Skeletal muscle channelopathy variants (14 pathogenic / likely pathogenic).
- Myopathy also has ClinVar records linked to CACNA1S variants; they fall mostly in different places as the Skeletal muscle channelopathy variants (3 pathogenic / likely pathogenic).
Diseases related to Skeletal muscle channelopathy
- Hypokalemic periodic paralysis, also linked to CACNA1S, CLCN1 and SCN4A
- Hyperkalemic periodic paralysis, also linked to CLCN1 and SCN4A
- Epilepsy, also linked to CACNA1S and SCN4A
- Migraine, also linked to CLCN1 and SCN4A
- Amyotrophic lateral sclerosis, also linked to SCN4A
- Myotonia, autosomal dominant form, also linked to CLCN1
- Congenital myotonia, autosomal recessive form, also linked to CLCN1
- Cardiac arrhythmia, also linked to SCN4A
- Sotos syndrome, also linked to SCN4A
- Diabetes mellitus, also linked to CACNA1S
- Myasthenic syndrome, also linked to SCN4A
- Paramyotonia congenita of Von Eulenburg, also linked to SCN4A
Frequently asked questions
Which genes have records linked to Skeletal muscle channelopathy?
This view contains 3 analyzed proteins: CLCN1, SCN4A, CACNA1S. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 18 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 5 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 25 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center